BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 32649343)

  • 21. Epidermodysplasia verruciformis: clinical presentation with varied forms of lesions.
    Sá NB; Guerini MB; Barbato MT; Di Giunta G; Nunes DH
    An Bras Dermatol; 2011; 86(4 Suppl 1):S57-60. PubMed ID: 22068772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidermodysplasia verruciformis.
    Dyall-Smith D; Cowen P; Varigos G
    Australas J Dermatol; 1989; 30(2):81-5. PubMed ID: 2486177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Condyloma and coincidental epidermodysplasia verruciformis acanthoma positive for human papillomavirus-14 and -21.
    Bartley B; Cho WC; Rady PL; Dai J; Curry JL; Milbourne A; Tyring SK; Torres-Cabala CA
    J Cutan Pathol; 2023 Jan; 50(1):47-50. PubMed ID: 36039682
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple metachronous skin squamous cell carcinomas and epidermodysplasia verruciformis in the head region: a human papilloma virus-associated disease.
    Weber BP; Fierlbeck G; Kempf HG
    Eur Arch Otorhinolaryngol; 1994; 251(6):342-6. PubMed ID: 7848644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A case of epidermodysplasia verruciformis associated with squamous cell carcinoma and Bowen's disease: a therapeutic challenge.
    Baskan EB; Tunali S; Adim SB; Turan A; Toker S
    J Dermatolog Treat; 2006; 17(3):179-83. PubMed ID: 16854762
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidermodysplasia verruciformis-like syndrome in association with systemic lupus erythematosus.
    Holmes C; Chong AH; Tabrizi SN; Downes N; Nindl I
    Australas J Dermatol; 2009 Feb; 50(1):44-7. PubMed ID: 19178492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidermodysplasia verruciformis in human immunodeficiency virus-infected patients: a marker of human papillomavirus-related disorders not affected by antiretroviral therapy.
    Jacobelli S; Laude H; Carlotti A; Rozenberg F; Deleuze J; Morini JP; Franck N; Gorin I; Avril MF; Dupin N
    Arch Dermatol; 2011 May; 147(5):590-6. PubMed ID: 21242344
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subungual Bowen disease in a patient with epidermodysplasia verruciformis presenting clinically as longitudinal melanonychia.
    Stetsenko GY; McFarlane RJ; Chien AJ; Fleckman P; Swanson P; George E; Argenyi ZB
    Am J Dermatopathol; 2008 Dec; 30(6):582-5. PubMed ID: 19033934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased risk of skin cancer associated with the presence of epidermodysplasia verruciformis human papillomavirus types in normal skin.
    Harwood CA; Surentheran T; Sasieni P; Proby CM; Bordea C; Leigh IM; Wojnarowska F; Breuer J; McGregor JM
    Br J Dermatol; 2004 May; 150(5):949-57. PubMed ID: 15149508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidermodysplasia verruciformis associated with neurofibromatosis type 1: coincidental association or model for understanding the underlying mechanism of the disease?
    Alpsoy E; Ciftçioğlu MA; Keser I; De Villiers EM; Zouboulis CC
    Br J Dermatol; 2002 Mar; 146(3):503-7. PubMed ID: 11952554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An epidermoid carcinoma case developed on old surgical scar in an epidermodysplasia verruciformis patient.
    Ozyazgan I; Kontas O; Gokahmetoglu S; Ozkul Y
    J Eur Acad Dermatol Venereol; 2005 Sep; 19(5):640-2. PubMed ID: 16164729
    [No Abstract]   [Full Text] [Related]  

  • 32. [Squamous cell carcinoma developing from epidermodysplasia verruciformis].
    Gross C; Basten D; Langner C
    Pathologe; 1999 Mar; 20(2):120-4. PubMed ID: 10321000
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Epidermodysplasia verruciformis with bowenoid degeneration and multiple basocellular and spinocellular epitheliomas].
    Depaoli M
    G Ital Dermatol Minerva Dermatol; 1971 Sep; 46(9):407-17. PubMed ID: 5110064
    [No Abstract]   [Full Text] [Related]  

  • 34. Skin cancer in epidermodysplasia verruciformis patients from Brazil.
    Oliveira WR; Rady PL; Festa C; Rivitti EA; Tyring SK
    J Eur Acad Dermatol Venereol; 2006 Oct; 20(9):1154-6. PubMed ID: 16987289
    [No Abstract]   [Full Text] [Related]  

  • 35. Common variable immunodeficiency syndrome associated with epidermodysplasia verruciformis.
    Vu J; Wallace GR; Singh R; Diwan H; Prieto V; Rady P; Tyring S; Duvic M
    Am J Clin Dermatol; 2007; 8(5):307-10. PubMed ID: 17902733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidermodysplasia verruciformis after cutaneous T-cell lymphoma: Periungual presentation.
    Cutlan JE; Rashid RM; Torres-Cabala C; Tyring SK; Thomas V
    Dermatol Online J; 2010 Aug; 16(8):12. PubMed ID: 20804689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidermodysplasia verruciformis.
    Jablonska S; Orth G
    Clin Dermatol; 1985; 3(4):83-96. PubMed ID: 2850863
    [No Abstract]   [Full Text] [Related]  

  • 38. Epidermodysplasia verruciformis.
    Lane JE; Bowman PH; Cohen DJ
    South Med J; 2003 Jun; 96(6):613-5. PubMed ID: 12938792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of human papillomavirus type 20 in epidermodysplasia verruciformis skin carcinogenesis.
    Yutsudo M; Tanigaki T; Kanda R; Sasagawa T; Inoue T; Jing P; Yong-Il H; Hakura A
    J Clin Microbiol; 1994 Apr; 32(4):1076-8. PubMed ID: 8027315
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidermodysplasia verruciformis-associated papillomavirus infection complicating human immunodeficiency virus disease.
    Berger TG; Sawchuk WS; Leonardi C; Langenberg A; Tappero J; Leboit PE
    Br J Dermatol; 1991 Jan; 124(1):79-83. PubMed ID: 1847068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.